Free Trial

Tema Oncology ETF (CANC) Holdings List

$40.97 -1.92 (-4.48%)
Closing price 04:00 PM Eastern
Extended Trading
$40.79 -0.18 (-0.44%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

What stocks does CANC hold?

The Tema Oncology ETF (CANC) top stock holdings include Genmab A/S, Revolution Medicines, and Eli Lilly and Company. The top 25 CANC holdings ordered by weight make up 79.30% of the total fund. CANC is an equity fund in the strategy category that invests in publicly traded companies and other investments, focused on theme strategies within the Global region. This page includes the top 25 CANC stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 25 CANC Holdings

RankCompanyCurrent PriceWeightShares Held
1
Genmab A/S Sponsored ADR stock logo
GMAB
Genmab A/S
$52.74
-4.3%
5.67%217,053
2
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
$177.65
-11.0%
5.20%59,055
3
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$1,368.85
-3.5%
5.18%8,147
4
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$146.76
-2.4%
5.07%74,880
5
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$29.58
-6.1%
4.67%315,472
6Novartis AGN/A4.07%54,926
7
AbbVie Inc. stock logo
ABBV
AbbVie
$288.48
-2.2%
3.95%29,331
8
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$122.96
-5.7%
3.82%63,005
9
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
$387.25
+2.5%
3.75%21,802
10
Exelixis, Inc. stock logo
EXEL
Exelixis
$68.71
-5.6%
3.48%113,486
11
Roche Holding AG stock logo
RHHBY
Roche
$59.35
-2.6%
3.14%111,549
12
BridgeBio Pharma, Inc. stock logo
BBIO
BridgeBio Pharma
$74.27
-4.6%
2.80%85,587
13
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$63.12
-1.7%
2.61%91,884
14
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$272.49
-1.4%
2.54%19,971
15
Enliven Therapeutics, Inc. stock logo
ELVN
Enliven Therapeutics
$44.79
-5.2%
2.47%118,429
16
CG Oncology, Inc. stock logo
CGON
CG Oncology
$64.80
-4.3%
2.38%81,181
17
Relay Therapeutics, Inc. stock logo
RLAY
Relay Therapeutics
$17.00
-5.7%
2.33%259,021
18
Immunome, Inc. stock logo
IMNM
Immunome
$17.91
-8.2%
2.28%269,014
19
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
$30.66
-5.3%
2.27%148,964
20AstraZeneca PLCN/A2.20%27,202
21
Legend Biotech Corporation Sponsored ADR stock logo
LEGN
Legend Biotech
$22.54
-1.0%
2.14%207,249
22
Iovance Biotherapeutics, Inc. stock logo
IOVA
Iovance Biotherapeutics
$7.71
-11.4%
2.12%479,670
23
Erasca, Inc. stock logo
ERAS
Erasca
$13.27
-11.0%
1.91%276,262
24
Summit Therapeutics PLC stock logo
SMMT
Summit Therapeutics
$14.19
-12.2%
1.63%217,527
25
Zai Lab Limited Unsponsored ADR stock logo
ZLAB
Zai Lab
$22.60
-0.9%
1.62%156,963

CANC Geographic Exposure

CANC's largest geographic exposure is United States at 92.2%, followed by Switzerland at 4.1%.

  • United States
    92.2%
  • Switzerland
    4.1%
  • United Kingdom
    2.4%
  • Israel
    0.7%
  • Netherlands
    0.5%

CANC Currency Exposure

CANC's largest currency exposure is USD at 66.4%, followed by CHF at 4.1%.

  • USD
    66.4%
  • CHF
    4.1%
  • GBP
    2.4%

CANC Sector Exposure

CANC's largest sector exposure is Health Care at 98.4%, followed by Consumer Discretionary at 0.6%.

  • Health Care
    98.4%
  • Consumer Discretionary
    0.6%

CANC Industry Exposure

CANC's largest industry exposure is Biotechnology at 88.8%, followed by Pharmaceuticals at 7.6%.

  • Biotechnology
    88.8%
  • Pharmaceuticals
    7.6%
  • Diversified Consumer Services
    2.0%
  • Health Care Providers & Services
    0.5%

CANC Sub-Industry Exposure

CANC's largest sub-industry exposure is Biotechnology at 81.1%, followed by Pharmaceuticals at 12.9%.

  • Biotechnology
    81.1%
  • Pharmaceuticals
    12.9%
  • Health Care Services
    0.5%

Related Companies and Tools


MarketBeat tracks Tema Oncology ETF holdings and portfolio composition, last updated on 11/1/2026.
From Our Partners